Six Dos and Don’ts of Define-XML
Discover the 6 dos and don’ts of creating compliant define.xml files for FDA submission with…
CertaraOctober 30, 2024
The Complete Guide to CDISC Standards Management
Learn how to easily manage and validate against CDISC data standards our complete guide to…
CertaraOctober 30, 2024
Certara Announces New Head of Clinical Pharmacology & Translational Medical Group
RADNOR, PA – October 30, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…
CertaraOctober 30, 2024
Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment
Abstract: T cell interaction in the tumor microenvironment is a key component of immuno-oncology therapy.…
CertaraOctober 29, 2024
Early Feasibility Assessment: A Method for Accurately Predicting Biotherapeutic Dosing to Inform Early Drug Discovery Decisions
Early Feasibility Assessment (EFA) can impact early drug discovery decisions such as determining feasibility of…
CertaraOctober 29, 2024
Early Feasibility Assessment: An Innovative Approach to Gain Confidence in Therapeutic Discovery
In this webinar Josh Apgar, PhD discusses Early Feasibility Assessment (EFA), a quantitative approach to early…
CertaraOctober 29, 2024
Certara to Participate in the Stephens Annual Investment Conference
RADNOR, Pa. — October 28, 2024 -- Certara, Inc. (Nasdaq: CERT), a global leader in…
CertaraOctober 28, 2024
Pharma Exec: MDMA Therapy for Mental Health Conditions
Certara's Dr. Fran Brown, SVP Drug Development Science, is featured in this recent Pharmaceutical Executive…
CertaraOctober 28, 2024
Adapting Value Stories for Global Healthcare Markets
Explore how to tailor healthcare value stories to global market access strategies, addressing cultural nuances,…
CertaraOctober 28, 2024
How To Respond to Health Authority Questions
Your biotech company has just submitted the marketing application for your first drug product. It’s…
CertaraOctober 25, 2024
